Company intelligence / Profile preview

Abvance Therapeutics

Nashville, Tennessee, United Statesabvancetherapeutics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Abvance Therapeutics has developed ABV100/ABV101, a novel coformulation of short acting insulin and glucagon designed to improve glycemic control while reducing the risk of hypoglycemia in people with diabetes who require rapid acting insulin. Proof-of-concept studies in type 1 diabetes patients have validated the glucose-dependent interaction between these peptides. The company recently secured $3.9 million from the Helmsley Charitable Trust to advance preclinical development[3][4]. Early clinical data suggest potential for better glycemic control with fewer hypoglycemic events compared to standard therapies[5].

Therapeutic areas: Endocrinology
Modalities: Peptides (insulin and glucagon combination)Protein-based therapeutics
Industry: Biotech

Drug pipeline

3 assets

ABV100

2 more assets in the full pipeline.

Partnerships

Vanderbilt University Cherrington Lab (foundational research)Helmsley Charitable Trust funding partner[3][4]

Beyond the preview

Go deeper on Abvance Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abvance Therapeutics.